Real-time enrollment status for this chronic kidney disease clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT04523727 |
| Recruiting Status | Suspended |
| Condition | Chronic Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 45 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Keryx Biopharmaceuticals |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04523727 is currently suspended participants. This clinical trial study for chronic kidney disease is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Keryx Biopharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04523727 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04523727 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.